Clinical Trial

Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast Cancer

Study acronym: SCAN-B
Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluates the genomic profiles of breast cancer in a prospective and population-based manner. In the first phase, breast tumors are analyzed by whole transcriptome RNA-sequencing. Gene expression profiles, mutational profiles, and transcript isoform-level data will be analyzed in the context of patient information, clinicopathological variables, and outcome, with the purpose to develop new molecular diagnostic assays for breast cancer. Additional genome-scale RNA, DNA, and protein analyses will be performed in the future.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2014-12-02; most recent amendment 2024-02-07.
Trial Details
NCT Number NCT02306096
Lead Sponsor Lund University
Collaborators: South Sweden Breast Cancer Group, Mrs. Berta Kamprad Foundation, U-CAN
Conditions Breast Neoplasms
Enrollment 20,000 participants
Start Date 2010-08
Primary Completion 2031-08 (estimated)
Study Completion 2031-08 (estimated)
Updated on ClinicalTrials.gov 2024-02-09